Dietary supplementation of probiotic Bacillus coagulans ATCC 7050, improves the growth performance, intestinal morphology, microflora, immune response, and disease confrontation of Pacific white shrimp, Litopenaeus vannamei
- 2019-04
- Fish & Shellfish Immunology 87
- K. Amoah
- Qin-Cheng Huang
- B. Tan
- Shuang Zhang
- S. Chi
- Qi‐hui Yang
- Hongyu Liu
- Xiao‐hui Dong
- PubMed: 30790661
- DOI: 10.1016/j.fsi.2019.02.029
Abstract
The present study assessed the effects of probiotic bacterium Bacillus coagulans ATCC 7050 (BC) fed at different inclusion levels (0 (BO), 1 × 106 (BC1), 1 × 107 (BC2) and 1 × 108 (BC3) CFU g-1 feed) on growth, feed utilization, body composition, intestinal morphology, microflora, immune response, and resistance to Vibrio parahaemolyticus infection in Litopenaeus vannamei. After 56 days of the feeding trial, the survival rate ranged from 83.33 to 94.17% with no significant difference between dietary treatments (P > 0.05). Dietary probiotic supplementation also affected the intestinal microflora composition. At the phylum level, Proteobacteria accounted for the majority of bacteria followed by Bacteroidetes irrespective of the group. At the genus level, the abundance of opportunistic pathogenic bacteria, such as Vibrio, Tenacibaculum, and Photobacterium significantly decreased (P < 0.05) with an increasing probiotic concentration, and BC3 group experiencing the least. Additionally, increasing probiotic inclusion in diet downregulated the abundance of Muricauda, Kangiella, and Shewanella in shrimps, with the least, observed in the BC3 group. However, beneficial bacteria Pseudoalteromonas significantly increased (P < 0.05) in the intestines of shrimp fed BC3 diet (P < 0.05) compared to other groups including the control. Compared to the control, a significant increase (P < 0.05) of the probiotic treated groups in the final weight, weight gain rate (WGR), specific growth rate (SGR), condition factor (K), activity of lysozyme (LYZ), acid phosphatase (ACP), superoxide dismutase (SOD), total protein (TP), albumin (ALB) in serum, glutathione peroxidase (GSH-Px) in serum and liver, and a significant decrease (P < 0.05) in feed conversion ratio (FCR), triglyceride (TG) in serum, and Malondialdehyde (MDA) in serum and liver were achieved. Increasing probiotic treatment again improved the digestive ability, thus; a significant increase in the activities of lipase, amylase, trypsin, and an enhancement in the villus height, villus width, and muscle thickness of the intestines of the shrimps which correspondingly alleviated intestinal injury. Furthermore, the supplementation of probiotics in challenge test significantly (P < 0.05) enhanced the resistance of shrimp against V. parahaemolyticus infection recording BC3 to receive the highest relative percentage survival (RPS) value of 76%. In conclusion, higher inclusion levels of probiotic BC at 1 × 108 CFU g-1 feed (BC3) in diets can be considered to enhance the growth, intestinal morphology and microflora, immune response and resistance to Vibrio parahaemolyticus of L. vannamei.
Keywords: Bacillus coagulans ATCC 7050; Growth; Immune; Litopenaus vannamei; Microflora.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Bacillus coagulans | Improved Digestive Enzyme Activity | Beneficial | Moderate |
Bacillus coagulans | Improved Growth Performance | Beneficial | Moderate |
Bacillus coagulans | Improved Immune Response | Beneficial | Large |
Bacillus coagulans | Improved Infection Resistance | Beneficial | Moderate |
Bacillus coagulans | Improved Intestinal Morphology | Beneficial | Large |
Bacillus coagulans | Reduced Opportunistic Pathogenic Bacteria Levels | Beneficial | Large |
Bacillus coagulans | Reduced Oxidative Stress | Beneficial | Moderate |
Bacillus coagulans LactoSpore 1 billion CFU | Enhanced Disease Resistance | Beneficial | Large |
Bacillus coagulans LactoSpore 1 billion CFU | Improved Feed Conversion Ratio | Beneficial | Moderate |
Bacillus coagulans LactoSpore 1 billion CFU | Improved Growth Performance | Beneficial | Moderate |
Bacillus coagulans LactoSpore 1 billion CFU | Improved Immune Response | Beneficial | Large |
Bacillus coagulans LactoSpore 1 billion CFU | Improved Intestinal Morphology | Beneficial | Large |
Bacillus coagulans LactoSpore 1 billion CFU | Reduced Pathogenic Bacterial Abundance | Beneficial | Large |
Bacillus coagulans MTCC 5856 | Improved Growth Performance | Beneficial | Moderate |
Bacillus coagulans MTCC 5856 | Improved Immune Response | Beneficial | Large |
Bacillus coagulans MTCC 5856 | Improved Infection Resistance | Beneficial | Moderate |
Bacillus coagulans MTCC 5856 | Improved Intestinal Morphology | Beneficial | Large |
Bacillus coagulans MTCC 5856 | Reduced Harmful Gut Microbiota | Beneficial | Large |
Bacillus coagulans ProDura | Enhanced Immune Resistance | Beneficial | Large |
Bacillus coagulans ProDura | Improved Immune Response | Beneficial | Large |
Bacillus coagulans ProDura | Improved Intestinal Morphology | Beneficial | Large |
Bacillus coagulans ProDura | Improved Microflora Composition | Beneficial | Moderate |
Bacillus coagulans SC208 | Improved Feed Utilization | Beneficial | Large |
Bacillus coagulans SC208 | Improved Growth Performance | Beneficial | Moderate |
Bacillus coagulans SC208 | Improved Immune Response | Beneficial | Large |
Bacillus coagulans SC208 | Improved Resistance to Pathogenic Infection | Beneficial | Large |
Bacillus coagulans SNZ-1969 | Enhanced Disease Resistance | Beneficial | Large |
Bacillus coagulans SNZ-1969 | Improved Growth Performance | Beneficial | Moderate |
Bacillus coagulans SNZ-1969 | Improved Immune Response | Beneficial | Large |
Bacillus coagulans SNZ-1969 | Improved Intestinal Morphology | Beneficial | Large |
Bacillus coagulans SNZ-1969 | Improved Microflora Composition | Beneficial | Moderate |
Bacillus coagulans Unique IS-2 | Enhanced Digestive Enzyme Activity | Beneficial | Large |
Bacillus coagulans Unique IS-2 | Improved Beneficial Intestinal Bacteria | Beneficial | Large |
Bacillus coagulans Unique IS-2 | Improved Feed Conversion Ratio | Beneficial | Moderate |
Bacillus coagulans Unique IS-2 | Improved Growth Performance | Beneficial | Moderate |
Bacillus coagulans Unique IS-2 | Improved Immune Response | Beneficial | Large |
Bacillus coagulans Unique IS-2 | Improved Resistance to V. parahaemolyticus Infection | Beneficial | Large |
Bacillus coagulans Unique IS-2 | Reduced Lipid Peroxidation | Beneficial | Large |
Bacillus coagulans Unique IS-2 | Reduced Opportunistic Pathogenic Bacteria Levels | Beneficial | Large |
Bacillus coagulans Unique IS-2 | Reduced Serum Triglyceride Levels | Beneficial | Large |